Showing 3,461 - 3,480 results of 18,441 for search 'significant ((((shape decrease) OR (we decrease))) OR (((a decrease) OR (mean decrease))))', query time: 0.58s Refine Results
  1. 3461
  2. 3462
  3. 3463

    Model performance comparison. by Shayla Naznin (13014015)

    Published 2025
    “…</p><p>Results</p><p>This study confirms a significant decline in under-5 mortality in Bangladesh over the study period, with machine learning models providing accurate predictions of future trends. …”
  4. 3464
  5. 3465
  6. 3466
  7. 3467
  8. 3468
  9. 3469
  10. 3470
  11. 3471
  12. 3472
  13. 3473
  14. 3474
  15. 3475
  16. 3476
  17. 3477

    Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
  18. 3478

    Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
  19. 3479

    Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
  20. 3480

    Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”